CA Stock MarketDetailed Quotes
ORTH Ortho Regenerative Technologies Inc
- 0.000
- 0.0000.00%
15min DelayMarket Closed Jun 28 09:30 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.000Pre Close0.00Turnover0.27052wk High0.00%Turnover Ratio51.04MShares0.24052wk Low-0.12EPS TTM0Float Cap1.000Historical High0.00P/E (Static)39.65MShs Float0.160Historical Low-0.14EPS LYR0.00%Amplitude--Dividend TTM0.00P/B1Lot Size--Div YieldTTM
Ortho Regenerative Technologies Inc Key Stats
Quarterly+Annual
YOY
| (Q1)Apr 30, 2022 | (FY)Jan 31, 2022 | (Q4)Jan 31, 2022 | (Q3)Oct 31, 2021 | (Q2)Jul 31, 2021 | (Q1)Apr 30, 2021 | (FY)Jan 31, 2021 | (Q4)Jan 31, 2021 | (Q3)Oct 31, 2020 | (Q2)Jul 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 12.18%-721K | -8.02%-3.22M | 1.21%-977K | 57.07%-653K | -6,890.91%-769K | -78.48%-821K | -87.37%-2.98M | -310.37%-989K | -119.16%-1.52M | 96.44%-11K |
| Net income from continuing operations | 31.56%-850K | -30.46%-4.92M | 32.81%-852K | -136.53%-1.92M | -43.26%-904K | -17.17%-1.24M | -51.61%-3.77M | -166.39%-1.27M | -6.97%-813K | 4.68%-631K |
| Operating gains losses | -1,841.30%-801K | 7,600.00%385K | -4,671.43%-320K | 21,533.33%649K | --10K | --46K | 110.64%5K | -69.57%7K | --3K | ---- |
| Depreciation and amortization | 0.00%15K | -22.47%69K | -5.26%18K | -21.74%18K | 5.88%18K | -50.00%15K | -24.58%89K | -40.63%19K | -17.86%23K | -43.33%17K |
| Remuneration paid in stock | -33.33%42K | -15.96%237K | -40.18%67K | -57.43%43K | 30.61%64K | 215.00%63K | 70.91%282K | 49.33%112K | 180.56%101K | 11.36%49K |
| Other non cashItems | 173.99%474K | -44.99%642K | -8.94%163K | -52.10%114K | 1.05%192K | -69.11%173K | 101.21%1.17M | -55.25%179K | 176.74%238K | 272.55%190K |
| Change In working capital | 221.77%399K | 148.94%368K | -39.47%-53K | 139.96%446K | -138.80%-149K | 588.89%124K | -1,028.40%-752K | 87.12%-38K | -7,871.43%-1.12M | 68.42%384K |
| -Change in receivables | -480.00%-19K | -150.00%-86K | -109.21%-43K | 93.53%-28K | -133.33%-20K | -93.59%5K | 391.43%172K | 7,883.33%467K | -1,070.27%-433K | 203.45%60K |
| -Change in prepaid assets | -110.68%-11K | 171.13%138K | ---35K | --25K | --45K | --103K | ---194K | ---- | ---- | ---- |
| -Change in payables and accrued expense | 2,581.25%429K | 143.29%316K | 108.04%25K | 165.74%449K | -153.70%-174K | 126.67%16K | -1,686.96%-730K | -7.61%-311K | -3,069.57%-683K | 13.29%324K |
| Interest paid (cash flow from operating activities) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---15K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 12.18%-721K | -8.02%-3.22M | 1.21%-977K | 57.07%-653K | -6,890.91%-769K | -78.48%-821K | -87.37%-2.98M | -310.37%-989K | -119.16%-1.52M | 96.44%-11K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | -1,000.00%-33K | 0 | 0 | -1K | -32K | -3K | -1K | -2K | 0 |
| Net PPE purchase and sale | --0 | -1,000.00%-33K | --0 | --0 | ---1K | ---32K | ---3K | ---1K | ---2K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | -1,000.00%-33K | --0 | --0 | ---1K | ---32K | ---3K | ---1K | ---2K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 1,804.44%2.57M | -76.96%1.16M | -59.61%1.03M | -100.04%-1K | 0 | -36.32%135K | 268.96%5.05M | 367.89%2.55M | 255.23%2.31M | -106.27%-20K |
| Net issuance payments of debt | ---- | -61.46%1.03M | ---- | ---- | ---- | ---- | 84.30%2.67M | 321.22%2.48M | -100.88%-6K | -107.84%-25K |
| Net common stock issuance | --2.7M | --0 | ---- | ---- | ---- | --0 | --2.47M | --72K | ---- | ---- |
| Proceeds from stock option exercised by employees | --0 | -31.52%63K | -95.71%3K | --0 | --0 | --60K | --92K | --70K | --17K | --5K |
| Net other financing activities | -274.67%-131K | 142.77%74K | --0 | 98.97%-1K | --0 | 2,600.00%75K | -124.68%-173K | -65.91%-73K | ---97K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 1,804.44%2.57M | -76.96%1.16M | -59.61%1.03M | -100.04%-1K | --0 | -36.32%135K | 268.96%5.05M | 367.89%2.55M | 255.23%2.31M | -106.27%-20K |
| Net cash flow | ||||||||||
| Beginning cash position | -86.84%313K | 687.75%2.38M | -74.04%210K | 3,617.39%855K | 2,887.04%1.61M | 687.75%2.38M | -42.37%302K | 40,550.00%809K | -45.24%23K | 68.75%54K |
| Current changes in cash | 357.66%1.85M | -201.06%-2.09M | -96.60%53K | -183.21%-654K | -2,383.87%-770K | -189.52%-718K | 1,031.08%2.07M | 413.16%1.56M | 1,886.36%786K | -410.00%-31K |
| Effect of exchange rate changes | 156.25%27K | 130.00%23K | 400.00%50K | --9K | --12K | ---48K | --10K | --10K | --0 | --0 |
| End cash Position | 35.77%2.19M | -86.84%313K | -86.84%313K | -74.04%210K | 3,617.39%855K | 2,887.04%1.61M | 687.75%2.38M | 687.75%2.38M | 40,550.00%809K | -45.24%23K |
| Free cash from | 15.47%-721K | -9.01%-3.25M | 1.31%-977K | 57.12%-653K | -6,900.00%-770K | -85.43%-853K | -87.55%-2.98M | -310.79%-990K | -119.45%-1.52M | 96.44%-11K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
%Chg